VIIV-202094

Study Sponsor: ViiV

Study Title

An evaluation of bone mineral density in HIV-1-infected adult subjects switching from a tenofovir-containing antiretroviral therapy regimen to a dolutegravir plus rilpivirine regimen

Medicine or Vaccine (generic name)

dolutegravir

Sponsor Identification Number

202094

Trial Registry Identification Number(#'s)

NCT02478632

Medical Condition

Infection, Human Immunodeficiency Virus

Phase

Phase 3

Link to study details on the ViiV Clinical Study Register

http://www.viiv-clinicalstudyregister.com/study/202094

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02478632

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This is a sub-study of 201636 and 201637. This study is available in CDISC format.

Date Added to this Site

January 2020